Jetmay Care Received Millions of Dollars in Series Pre-A Financing

According to Iyiou News, Jetmay Care just completed millions of dollars in Series Pre-A financing. This round of financing was led by ASBV China. Jetmay Care will use the funds to improve its product development, equipment production and marketing effort.

Founded in October 2017, Jetmay Care specializes in the development, production, and technical services of IVD testing products. In the one and a half years since its establishment, Jetmay Care has gain three technologies: multi-functional immunochromatography, time-resolved fluorescence and Raman molecular detection.

At this moment, Jetmay Care has independently developed a number of "whole blood testers" and dozens of diagnostic reagents including cardiovascular and cerebrovascular, inflammatory, and renal failure. “In the future development of Jetmay Care, more mature and stable technologies around the world will be introduced to build more POCT products for disease management,” Dr. Hongjian Liu, Chairman of Jetmay Care said. In addition, Jetmay Care has invested millions of dollars for the construction of the factory building in Shenzhen.

At the end of 2018, Jetmay Care signed an agreement with JanaCare to develop a small AinaX detector for JanaCare, and to promote Jetmay Care's cost-effective cardiovascular testing products to community clinics. It also helped Janacare develop in India and North America. In May 2019, Jetmay Care began to promote POCT products in various countries such as the Middle East and South America, and vigorously promoting the overseas market of the IVD industry.

ASBV China focuses on venture capital investments in early and mid-stage companies in biomedical, health, TMT, hardware technology and cleantech.